Press Releases
Glooko Recognized as Finalist for the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH
Best in Class finalist in Cardiometabolic, Obesity & Diabetes category PALO ALTO, Calif., October 27, 2026 — Glooko, Inc. an enterprise software...
Read MoreGlooko Expands Ambulatory Diabetes Management Offerings with GestationalCare™ Module for Diabetes in Pregnancy
Pregnancy-specific solution helps care teams prioritize risk, review fasting and post-meal patterns, engage individuals between visits, and support postpartum...
Glooko Introduces the First and Only Pump Settings EHR Integration to Bring Insulin Pump Data Directly Into Clinical Workflows
First-of-its-kind device-agnostic capability delivers critical pump configuration data into EHR flowsheets, helping clinics reduce manual documentation...
Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud
Glooko announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool IV Cloud for patient-specific insulin dosing in hospitals.
Glooko and mylife Diabetes Care Expand Diabetes Data Management Partnership
Through an expanded partnership between Glooko and mylife Diabetes Care, Glooko will serve as the primary data management provider for mylife products.
Glooko Wins “Best Overall MedTech Software” in 2026 MedTech Breakthrough Awards
Glooko is the winner of the 2026 MedTech Breakthrough ‘Best Overall MedTech Software’ award for its diabetes and glycemic management software portfolio.
Mark Clements of Glooko recognized on Becker’s Healthcare’s 2026 ‘Great leaders in healthcare’ list
Glooko announced that Chief Medical and Strategy Officer Mark Clements, M.D., Ph.D., was named one of Becker's Healthcare's 2026 'Great leaders in healthcare.'